Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares UltraPro Short S&P500 ETF
SPXU
5
Tradr 2X Short TSLA Daily ETF
TSLQ
US Stock MarketDetailed Quotes
TNYA Tenaya Therapeutics
- 0.5100
- +0.0350+7.37%
Close May 1 16:00 ET
- 0.4906
- -0.0194-3.80%
Pre 08:26 ET
82.94MMarket Cap-0.39P/E (TTM)
0.5100High0.4621Low1.70MVolume0.4680Open0.4750Pre Close839.83KTurnover2.88%Turnover RatioLossP/E (Static)162.63MShares4.890052wk High0.89P/B30.09MFloat Cap0.394152wk Low--Dividend TTM59.00MShs Float32.0000Historical High--Div YieldTTM10.08%Amplitude0.3941Historical Low0.4940Avg Price1Lot Size
Tenaya Therapeutics Stock Forum
Sign in to post a comment
$Tenaya Therapeutics (TNYA.US)$
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
Thursday, 24th April at 2:07 pm
RIDGE is Largest Natural History Study Conducted with More Than 175 Participants Enrolled to Date with Arrhythmogenic Right Ventricular Cardiomyopathy Due to Mutations in the PKP2 Gene
Patients Experience High Burden of Arrhythmias and Severe Disease Progression Despite Standard...
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
Thursday, 24th April at 2:07 pm
RIDGE is Largest Natural History Study Conducted with More Than 175 Participants Enrolled to Date with Arrhythmogenic Right Ventricular Cardiomyopathy Due to Mutations in the PKP2 Gene
Patients Experience High Burden of Arrhythmias and Severe Disease Progression Despite Standard...
2
1
$Tenaya Therapeutics (TNYA.US)$
Revolutionary Gene Therapy Transforms Severe Heart Disease Patients in Landmark Trial
Revolutionary Gene Therapy Transforms Severe Heart Disease Patients in Landmark Trial
$Tenaya Therapeutics (TNYA.US)$
Revolutionary Heart Disease Treatment: Gene Therapy Reverses Cardiac Damage in Landmark Study
Revolutionary Heart Disease Treatment: Gene Therapy Reverses Cardiac Damage in Landmark Study
1
$Tenaya Therapeutics (TNYA.US)$
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
Monday, 24th March at 8:30 am
SOUTH SAN FRANCISCO, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced th...
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
Monday, 24th March at 8:30 am
SOUTH SAN FRANCISCO, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced th...
1
1
$Tenaya Therapeutics (TNYA.US)$
Major Breakthrough: Tenaya's Gene Therapy Trial Reveals Critical One-Year Heart Disease Data
Major Breakthrough: Tenaya's Gene Therapy Trial Reveals Critical One-Year Heart Disease Data
$Tenaya Therapeutics (TNYA.US)$ sold at 0.68.
2
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release;...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release;...
47
8
1
No comment yet
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Trytosaveabit : Tell me you seen the great results outa BCTX Brother! Yes needs to be replicated lots! But IMO its pretty amazing so far! And if repeatable only sometimes? Could be soooo wonderful for so many!